FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/081629 [Registered on: 04/03/2025] Trial Registered Prospectively
Last Modified On: 28/02/2025
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Environmental surveillance, Cohort and Cross-sectional study. 
Study Design  Other 
Public Title of Study   Monitoring wastewater for identifying multiple microorganisms in Vellore 
Scientific Title of Study   Vellore multipathogen Wastewater based Environmental Surveillance 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Venkata Raghava Mohan 
Designation  Professor and Head 
Affiliation  Christian Medical College 
Address  Department of Community Medicine, Christian Medical College, Vellore

Vellore
TAMIL NADU
632002
India 
Phone  09443109044  
Fax  04162262788  
Email  venkat@cmcvellore.ac.in  
 
Details of Contact Person
Scientific Query
 
Name  Venkata Raghava Mohan 
Designation  Professor and Head 
Affiliation  Christian Medical College 
Address  Department of Community Medicine, Christian Medical College, Vellore


TAMIL NADU
632002
India 
Phone  09443109044  
Fax  04162262788  
Email  venkat@cmcvellore.ac.in  
 
Details of Contact Person
Public Query
 
Name  Venkata Raghava Mohan 
Designation  Professor and Head 
Affiliation  Christian Medical College 
Address  Department of Community Medicine, Christian Medical College, Vellore


TAMIL NADU
632002
India 
Phone  09443109044  
Fax  04162262788  
Email  venkat@cmcvellore.ac.in  
 
Source of Monetary or Material Support  
Bill and Melinda Gates Foundation, USA 
 
Primary Sponsor  
Name  Bill and Melinda Gates Foundation, USA 
Address  P. O. Box 23350, Seattle Washington 98102, USA 
Type of Sponsor  Other [Private Foundation] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Venkata Raghava Mohan  Christian Medical College and Vellore Hospital  Department of Community Medicine, Vellore College Campus Thorapadi Post, Bagayam, Vellore, 632012
Vellore
TAMIL NADU 
04162284207
04162262788
venkat@cmcvellore.ac.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Review Board, Christian Medical College, Thorapadi Post, Bagayam Vellore, Tamil Nadu 632012  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Family members above 15 years for TB survey. Adults and children volunteers for cholera sero survey 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  0.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Healthy volunteers willing to participate in a longitudinal serosurvey among 1080 rural and 1080 urban participants to estimate the seroincidence of Vibrio cholerae in the community.

All individuals above the age of 15 years from ~20,000 families in urban areas and all families from rural areas (three or four villages of Kaniyambadi block bordering Jawadhi hills) where wastewater surveillance is implemented for estimating the burden of pulmonary tuberculosis and drug-resistant tuberculosis.  
 
ExclusionCriteria 
Details  If the participants is not willing to participate in the study. Refuse to provide consent. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Detection rates of Salmonella typhi - Waste water surveillance.  Fortnightly - two months from 54 urban sites followed by 20 urban sites for 30 months 
 
Secondary Outcome  
Outcome  TimePoints 
Detection rates of avian influenza virus - Waste water & samples from poultry markets.  Fortnightly - 50 sampling location including 25 waste water sampling locations and 25 from poultry markets (20 urban & five rural areas in each) for 32 months  
Detection rates of Vibrio cholerae - Waste water surveillance.   Fortnightly - 25 waste water sampling locations (20 urban & five rural) for 32 months 
Seroincidence for cholera - Dried blood spots.  3 time points; baseline, 4-6 months, 10-12 months. Cohort of 1080 participants from rural and urban area 
Detection rates of MTBC, and TB AMR genes - Waste water surveillance.  Fortnightly - 25 waste water sampling locations (20 urban & five rural) for 32 months 
Prevalence of PTB, MDR-TB, and XDR TB in the community - Symptom screening & Sputum testing.  Individuals above 15 years from ~20,000 families from urban areas and all families in the rural villages. All individuals screened positive for their symptom will be sputum tested 
 
Target Sample Size   Total Sample Size="78726"
Sample Size from India="78726" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   17/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  


Wastewater-based surveillance has become a vital tool in public health monitoring, drawing on years of environmental surveillance efforts for pathogens like poliovirus. The majority of the wastewater surveillance conducted across the globe is mostly focused on monitoring single pathogens. The ongoing wastewater surveillance in Vellore City under the Department of Community Health since 2022, is mainly aimed at establishing baseline detection rates across different sampling sites for Salmonella typhi and Salmonella paratyphi A in the environment and monitoring longitudinal trends after phased TCV introduction in the study area as part of the Vellore Typhoid Vaccine Impact Trial.

Wastewater surveillance for Salmonella typhi and Salmonella paratyphi A

This proposal will leverage the existing environmental surveillance to a multiple-pathogen-based environmental surveillance model. In this proposal, we plan to extend the current Salmonella typhi and Salmonella paratyphi A surveillance at 20 sites from the urban wards, for an additional 30 months after the extension of current surveillance at 54 sites for an additional two months (August-September 2025). These 20 sites will be selected based on the previous performance in detecting Salmonella typhi and suitability for monitoring other pathogens.

Wastewater surveillance for avian influenza

In addition, we will implement wastewater (WW) surveillance for avian influenza. Fortnightly WW samples will be collected from 50 sampling locations (predominantly urban with important rural landmarks) on the sewage networks, poultry markets, and large retail poultry shops, and swabs from bird markets (surface swabs of cages, fecal samples, areas with fecal contamination) for a period of 32 months. This surveillance will allow us to detect the circulating strains of the influenza virus in the study area, study temporal trends, and compare rural-urban prevalence.

Wastewater surveillance for Vibrio cholerae

For Vibrio cholerae, we will be collecting fortnightly WW samples from 25 community sampling locations (20 urban and five rural) in Vellore for 32 months. Baseline rates of environmental detection of Vibrio cholerae will be estimated and this will enable urban and rural comparisons.

Serosurveillance surveillance for Vibrio cholerae

Additionally, we will be conducting a longitudinal serosurvey among 1080 rural and 1080 urban participants to estimate the seroincidence of Vibrio cholerae in the community by assessing the levels of Vibrio cholerae-specific antibodies. We will be collecting dried blood spots at baseline, 4-6 months, and 10-12 months into the study for this purpose. We will be assessing the association between the seroincidence of cholera and overall WW positivity, adjusting for the population size.

Wastewater surveillance for MTBC and AMR genes associated with MTB resistance (MDR and XDR)

We will also collect fortnightly WW samples to detect MTBC and AMR genes associated with MTB resistance (MDR and XDR), to monitor trends in the five rural and the 20 urban wastewater sampling sites for 32 months.

Community burden of pulmonary tuberculosis and drug-resistant tuberculosis

A community screening based on symptoms for pulmonary tuberculosis (PTB) will be conducted among all individuals above the age of 15 years from ~20,000 families in urban areas and all families from rural areas (three or four villages of Kaniyambadi block bordering Jawadhi hills) where wastewater surveillance is implemented. A sputum sample will be collected from those who are positive for symptoms of PTB from their houses and will be processed by the GeneXpert test, a highly advanced molecular diagnostic test that detects PTB and determines drug resistance, especially for rifampicin, which can indicate the presence of multi-drug-resistant TB. Samples testing positive by the GeneXpert test will be tested using the Xpert MTB/XDR assay, which can detect extensive drug resistance.

 
Close